Table 1.
Abnormal metabolism associated with autism spectrum disorder from metabolomic studies in urine samples
| Ref and Subjects | Age (years) | Method | Categories of Metabo- lite/ Metabolic pathway involvement |
Changes in metabolites compared to typical children |
Interpretation | |
|---|---|---|---|---|---|---|
| Increase | Decrease | |||||
| Gevi et al. 2020 | ||||||
| 40 ASD compared with 40 typical children | 3-8 | Untargeted approach using UHPLC-MS | Neurotransmitter | Glutamate | GABA | There are abnormalities of neurotransmitters and metabolites related to microbiota-brain-gut axis in the urine of children with ASD. |
| Pyridoxal phosphate | ||||||
| Neurotransmitter/microbiota-brain-gut axis | 4-Cresol | Noradrenaline | ||||
| Ascorbate | Adrenaline | |||||
| Homovanillic acid | MHPG Vanillylmandelic acid |
|||||
| Liang, Ke et al. 2020 | ||||||
| 40 ASD compared with 40 typical children | 3-12 | Untargeted approach using UHPLC-QTOF/MS | Nicotinate and nicotinamide metabolism | Nicotinamide | There are abnormalities of nicotinamide, phosphorylcholine, amino acid, acetyl-CoA synthase, lysine, nucleosides, neurotransmitter, naphthalene metabolites, sialic acid, purine, and lipid metabolism in urine of children with ASD. | |
| Phosphorylcholine metabolism | Phosphorylcholine | |||||
| Amino acid metabolism |
Glycylglutamate Alanylthreonine Threonylaspartate Histidylproline Lysylproline Valylmethionine Methionylglutamine |
Prolylserine | ||||
| Acetyl-CoA synthase | Acetylcarnitine | |||||
| Tryptophan kynurenine pathway | D-neopterin 7,8-Dihydroneopterin Anthranilic acid |
|||||
| Catabolism of lysine | 5-Aminopentanoic acid | |||||
| Modified nucleosides | 1-Methyladenosine 3’-O-Methylinosine |
|||||
| Neurotransmitter | N-Acetylaspartylglutamate | |||||
| Naphthalene metabolites | 1-Naphthol | |||||
| Sialic acid pathway | N-Acetylneuraminic acid | |||||
| Purine metabolism | Deoxyinosine | |||||
| Lipid metabolism | Behenic acid | |||||
| Other | Bethanechol cation S-Methyl-5’-thioadenosine |
|||||
| Liang, Xiao et al. 2020 | ||||||
| 22 ASD compared with 22 non-ASD siblings | 3-9 | Untargeted approach using 1H-NMR | Cysteine metabolism | Taurine | There are abnormalities of cysteine, methionine, oxidative stress, sulfur, and tryptophan-serotonin-melatonin metabolic pathway in urine of children with ASD. | |
| Methionine cycle | Taurine | |||||
| Reactive oxidative stress | Taurine | |||||
| Sulfur metabolism | Taurine | |||||
| Tryptophan-serotonin-melatonin pathway | Tryptophan Serotonin |
Melatonin | ||||
| Others | Creatine | Butyrate Citrate Lactate Pantothenate Trigonelline |
||||
| Mussap et al. 2020 | ||||||
| 31 ASD compared with 26 typical children | 2-11 | Untargeted approach using GC-MS | Oxidative stress | Cystine | 7-Methylxanthine Uric acid |
There are differences of metabolite levels resulting from oxidative stress, mitochondrial dysfunction, sugar metabolism, gut dysbiosis, and diet in urine of children with ASD compared to those of typically developing children. |
| Mitochondrial dysfunction | Lactic acid | |||||
| Sugar metabolism | Scylloinositol | |||||
| Gut dysbiosis | Quinic acid Hippuric acid Tryptophan Indole-3-acetic acid Allyl thioacetic acid Leucine |
|||||
| Diet | 1-Methylhistidine | |||||
| Others | Aminomalonic acid | |||||
| Olesova et al. 2020 | ||||||
| 24 ASD compared with 13 typical children | 6-10 | Targeted approach using UHPLC-QqQ-MS/MS | Reactive oxidative stress | Methylguanidine N-acetylarginine |
There are abnormalities of reactive oxidative stress and gut bacteria metabolism in the urine of children with ASD. | |
| Gut bacteria metabolism | Indoxyl sulphate Indole-3-acetic acid |
|||||
| Liu et al. 2019 | ||||||
| 57 ASD compared with 81 typical children | 2-12 | Targeted approach using LC-MS/MS | Ornithine (Urea) cycle Ornithine (Urea) cycle |
Ornithine-to-Citrulline ratio | Proline | There are abnormalities of ornithine (urea) cycle, methionine, lysine, reactive oxidative stress, tryptophan-serotonin metabolism in urine of children with ASD. |
| Arginine-to-Ornithine | Citrulline | |||||
| Arginine 4-Hydroxyproline |
Aspartic acid | |||||
| Methionine cycle | Methionine sulfoxide | Homocysteine 5-Aminovaleric acid a-Aminoadipic acid Ethanolamine |
||||
| Lysine metabolism | Lysine | |||||
| Reactive oxidative stress | Anserine Carnosine |
|||||
| Tryptophan-Serotonin metabolism | 5-Hydroxytryptamine | |||||
| Others | 2-Aminoisobutyric acid | |||||
| Chen et al. 2019 | ||||||
| 156 ASD compared with 64 typical children | NA | Untargeted approach using GC/MS | Phenylalanine metabolism | Phenylactic acid | There are abnormalities of phenylalanine, TCA cycle, bone metabolism, mammalian-microbial co-metabolism in urine of ASD. | |
| TCA cycle | Aconitic acid Carboxycitric acid |
|||||
| Bone metabolism | Phosphoric acid | |||||
| Mammalian-microbial co-metabolism | 3-Oxoglutaric acid Carboxycitric acid |
|||||
| Others | 3-Hydroxy-3-methylglutaric | Fumaric | ||||
| Creatinine | N-Acetylcysteine | |||||
| Oxalic | Malonic | |||||
| Pyruvic | Tricarballylic | |||||
| 4-cresol | Glycolic | |||||
| 2-hydroxybutyric | Malic Tartaric 3-Hydroxyglutaric 2-Oxoglutaric |
|||||
| Xiong et al. 2019 | ||||||
| 51 ASD compared with 51 typical children | 3-7 | Untargeted approach using HPLC-QTOF-MS | Adenosine-Adenine pathway | Adenine | There are abnormalities of adenosine-adenine pathway, methylation regulation of retinoic acid-RORA pathway, and arginine metabolism, predominantly in female patient with ASD. | |
| Methylation regulation of retinoic acid-RORA pathway | 2-Methylguanosine 7alpha-Hydroxytestololactone |
|||||
| Arginine metabolism | Creatinine | Creatine | ||||
| Bitar et al. 2018 | ||||||
| 40 ASD compared with 40 typical children | NA | Untargeted approach using 1H-NMR and LC-MS | Glycine, serine and threonine metabolism | Phosphoserine | Threonine Creatine Serine |
There are abnormalities in amino acids, nicotinic acid, TCA cycle, purine, vitamin, and fatty acid metabolism in urine of ASD. |
| Phenylalanine metabolism | N-acetylphenylalanine Tyrosine Hydroxybenzoic acid |
|||||
| Glutamate, Arginine and Proline metabolism | Glutamic acid | Creatine Hydroxyproline |
||||
| Histidine metabolism | Glutamic acid | Urocanic acid | ||||
| Cysteine and Methionine metabolism | Phosphoserine | Cysteic acid Serine |
||||
| Propanoate metabolism | 2-hydroxybutyric acid | |||||
| Nicotinate and nicotinamide metabolism | Nicotinamide ribotide Trigonelline |
|||||
| TCA cycle | Citric acid | |||||
| Purine metabolism | 5-amino-imidazole-4-carboxamide | Guanine | ||||
| Vitamin B6 metabolism | Riboflavin | |||||
| Fatty acid oxidation | N-amidino aspartic acid Acetylcarnitine |
|||||
| Others | Glycerol-3-phosphate Cholic acid |
Methyl acetoacetic acid | ||||
| Lussu et al. 2017 | ||||||
| 21 ASD compared with 21 non-ASD siblings | 4-16 | Untargeted approach using 1H-NMR | Neurotransmitter | Glycine | Glutamate | There are abnormalities of neurotransmitter, tryptophan-serotonin, mammalian-microbial co-metabolism, oxidative stress metabolism in urine of ASD. |
| Tryptophan-serotonin metabolism | Tryptophan | |||||
| Mammalian-microbial co-metabolism | Hippurate | |||||
| Oxidative stress | Taurine Lactate |
|||||
| Others | Creatine D-threitol |
Valine Betaine Creatinine |
||||
| Xiong et al. 2016 | ||||||
| 62 ASD compared with 62 typical children | 1.5-7 | Untargeted approach using GC/MS | Mammalian-microbial co-metabolism | 3-(3-hydroxyphenyl)-3-Hydroxypropionic acid 3-Hydroxyphenylacetic acid 3-Hydroxyhippuric acid |
There are abnormalities in mammalian-microbial co-metabolism in urine of ASD. | |
| Gevi et al. 2016 | ||||||
| 30 ASD compared with 30 typical children | 2-7 | Untargeted approach using LC-MS | Purine metabolism | Inosine Hypoxanthine Xanthosine |
Adenosine diphosphate | There are abnormalities of nucleic acid (purine, pyrimidine), amino acid (tryptophan), vitamins (B1, B2, B6, and pantothenate), mammalian-microbial co-metabolism, glutathione, pentose phosphate pathway, benzoate degradation, and carbohydrate metabolism in urine of ASD. |
| Pyrimidine metabolism | Uridine | |||||
| Tryptophan metabolism | Xanthurenic acid Quinolinic acid Tryptophan |
Kynurenine | ||||
| Mammalian-microbial co-metabolism | Indolyl 3-acetic acid Indolyl lactate |
|||||
| Disaccharide metabolism | Trehalose/sucrose | Cellobiose | ||||
| Other amino acid metabolism | Phenylalanine Histidine |
Methionine | ||||
| Glutathione metabolism | Pyroglutamic acid | |||||
| Pentose Phosphate Pathway | 6-phospho-D-gluconic acid Ribose |
|||||
| Benzoate degradation | p-cresol | p-hydroxybenzoate | ||||
| Vit B1 metabolism | Thiamine | |||||
| Vit B2 metabolism | Riboflavin | |||||
| Vit B6 metabolism | 4-pyriodic acid | |||||
| Pantothenate and CoA metabolism | Glucose-6-phosphate | |||||
| Glycolysis | Glucose-6-phosphate | |||||
| Diémé et al. 2015 | ||||||
| 30 ASD compared with 32 typical children | NA | Untargeted approach using 1H-NMR, 1H-13C-NMR and LC-HRMS | Reactive oxidative stress | N-acetylarginine | Methylguanidine Guanidinosuccinic acid |
There are abnormalities in reactive oxidative stress, tyrosine, pyrimidine, and mammalian-microbial co-metabolism in urine of ASD. |
| Tyrosine metabolism | Dihydroxy-1H-indole glucuronide I | |||||
| Pyrimidine metabolism | Dihydrouracil | |||||
| Mammalian-microbial co-metabolism | Indoxyl Indoxyl sulfate Alpha-N-Phenylacetyl-L-glutamine p-cresol sulfate |
Desaminotyrosine | ||||
| Others | N-Acetylasparagine Valine Glucuronic acid |
|||||
| Cozzolino et al. 2014 | ||||||
| 24 ASD compared with 21 typical children | 6.9 +/−2.1 | Untargeted approach using Solid-phase microextraction with GC/MS | Leucine metabolism | 3-Methylbutanal (under acid conditions) | There are abnormalities in leucine, fatty acid, and degradation of carbohydrate metabolism in urine of ASD. | |
| Peroxidation of fatty acid | 3-Methylbutanal (under acid conditions) 2-Methylbutanal (under acid conditions) |
|||||
| Dietary degradation of carbohydrate | 2-Methylmercaptofuran (under acid conditions) 2-Pentylfuran (under acid conditions) |
|||||
| Others | 3-Methylcyclopentanone (under acid conditions) | 2-Heptanone (under alkaline conditions) | ||||
| Hexane (under acid conditions) | Ethanol (under acid conditions) | |||||
| 2,3-Dimethylpyrazine (under alkaline conditions) | Dimethyl trisulfide (under acid conditions) | |||||
| 2-Methylpyrazine (under alkaline conditions) | Methoxy-phenyloxime (under alkaline conditions) | |||||
| Isoxazole (under alkaline conditions) | 3-Ethylpyridine (under alkaline conditions) Acetophenone (under alkaline conditions) |
|||||
| Noto et al. 2014 | ||||||
| 21 ASD compared with 21 non-ASD siblings | 4-16 | Untargeted approach using GC/MS | Mammalian-microbial co-metabolism | 3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid Glycolic acid 4-Hydroxyhippuric acid |
There are abnormalities of TCA cycle, Tryptophan, Glutathione, oxidative cleavage of N-acetylglucosamine, Tyrosine, pentose phosphate pathway, and mammalian-microbial co-metabolism in urine of ASD. | |
| TCA cycle | Aconitic acid | |||||
| Tryptophan metabolism | Tryptophan | |||||
| Glutathione metabolism | Pyroglutamic acid | |||||
| Oxidative cleavage of N-acetylglucosamine | Erythronic acid | |||||
| Tyrosine pathway | Phenylalanine Tyrosine 4-Hydroxyphenylacetic acid Homovanillic acid |
|||||
| Pentose Phosphate Pathway | Ribose Arabinofuranose Threitol Polyols arabitol Xylitol |
|||||
| From dietary sources | Fructose 1,2,3-Butanetriol Propylene glycol |
|||||
| Mavel et al. 2013 | ||||||
| 30 ASD compared with 28 typical children | 6-14 | Targeted approach using 1H-NMR | Organic acid | Succinic acid | There are abnormalities of organic acid and amino acid metabolism in urine of ASD. | |
| Amino acid | Glycine | Creatine | ||||
| β-alanine Taurine |
3-methylhistidine | |||||
| Emond et al. 2013 | ||||||
| 26 ASD compared with 24 typical children | 6-14 | Untargeted approach using GC/MS | Mammalian-microbial co-metabolism | 1H-indole-3-acetate Hippurate 3-hydroxyhippurate |
There are abnormalities of organic acid, fatty acid, phenols, and mammalian-microbial co-metabolism in urine of ASD. | |
| Organic acid | Succinate Glycolate |
|||||
| Fatty acid | Palmitate Stearate 3-methyladipate |
|||||
| Phenols | p-Hydroxy mandelate 3-hydroxyphenylacetate |
|||||
| Ming et al. 2012 | ||||||
| 48 ASD compared with 53 typical children | 6-14 | Untargeted approach combined using UPLC-MS/MS and GC/MS | Histidine catabolism | Trans-Urocanate | There are abnormalities of amino acid (Histidine, Lysine, Tryptophan, Leucine), reactive oxidative stress, and mammalian-microbial co-metabolism in urine of ASD. | |
| Lysine and tryptophan catabolism | Glutaroylcarnitine | |||||
| Leucine catabolism | 3-Methylglutaroylcarnitine | |||||
| Mammalian-microbial co-metabolism | 2-(4-Hydroxyphenyl) propionate | 3-(3-Hydroxyphenyl) propionate | ||||
| Taurocholenate sulfate | 5-Amino-valerate | |||||
| Reactive oxidative stress | Carnosine Urate |
|||||
| Amino acid and gamma-glutaryl amino acids | Glycine Serine Threonine Alanine β-alanine Histidine Taurine N-acetylglycine Gamma-glutamylleucine Gamma-glutamyltyrosine Gamma-glutamylthreonine |
|||||
| Yap et al. 2010 | ||||||
| 39 ASD compared with 28 non-ASD siblings 34 typical children | 3-9 | Untargeted approach using 1H-NMR | Nicotinic acid metabolism | N-methyl-2-pyridone-5-carboxamide N-methyl nicotinic acid N-methyl nicotinamide |
There are abnormalities of nicotinic acid, amino acid, mammalian microbial co-metabolism in urine of ASD | |
| Amino acid metabolism | Taurine N-acetyl glycoprotein fragment Succinate |
Glutamate | ||||
| Mammalian microbial co-metabolites | Dimethylamine | Hippurate Phenylacetylglutamine |
||||
| Nadal-Desbarats et al. 2014 | ||||||
| 30 ASD compared with 28 typical children | 6-14 | Targeted approach using combined 1H-NMR and 2D 1H-13C HSQC NMR | TCA cycle | Succinate | There are abnormalities of TCA cycle and glutamate metabolism in urine of ASD. | |
| Glutamate metabolism | Glutamate | |||||
| Others | 3-methylhistidine | |||||
ASD autism spectrum disorder, TCA tricarboxylic acid cycle, UPLC-MS/MS ultra-performance liquid chromatography—tandem mass spectrometer, UHPLC-MS ultra-high-performance liquid chromatography-mass spectrometry, UHPLC-QTOF/MS ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry, UHPLC-QqQ-MS/MS ultra-high-performance liquid chromatography-tandem triple quadrupole-mass spectrometry, LC–MS liquid chromatography–mass spectrometry, LC–MS/MS liquid chromatography–tandem mass spectrometry, LC-HRMS liquid chromatography–high resolution mass spectrometry, GC–MS gas chromatography–mass spectrometry, 1H-NMR hydrogen-1 nuclear magnetic resonance, 1H-13C-NMR hydrogen-1 and carbon-13 nuclear magnetic resonance, 2D 1H-13C HSQC NMR two-dimensional hydrogen-1 and carbon-13 heteronuclear single quantum correlation nuclear magnetic resonance; MS/MS: tandem mass spectrometry, HPLC-QTOF-MS high-performance liquid chromatography-quadrupole-time of flight mass spectrometry, GABA gamma-aminobutyric acid, RORA related orphan receptor alpha, NA data not available